Combining Hepatic Percutaneous Perfusion with Ipilimumab plus Nivolumab in advanced uveal melanoma (CHOPIN): study protocol for a phase Ib/randomized phase II trial

BACKGROUND: While immune checkpoint inhibition (ICI) has revolutionized the treatment of metastatic cutaneous melanoma, no standard treatments are available for patients with metastatic uveal melanoma (UM). Several locoregional therapies are effective in the treatment of liver metastases, such as pe...

Descripción completa

Detalles Bibliográficos
Autores principales: Tong, T. M. L., van der Kooij, M. K., Speetjens, F. M., van Erkel, A. R., van der Meer, R. W., Lutjeboer, J., van Persijn van Meerten, E. L., Martini, C. H., Zoethout, R. W. M., Tijl, F. G. J., Blank, C. U., Burgmans, M. C., Kapiteijn, E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8842930/
https://www.ncbi.nlm.nih.gov/pubmed/35152908
http://dx.doi.org/10.1186/s13063-022-06036-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8842930/
https://www.ncbi.nlm.nih.gov/pubmed/35152908
http://dx.doi.org/10.1186/s13063-022-06036-y

Ejemplares similares